The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 22, 2015
- Accepted in final form December 27, 2015
- First Published February 10, 2016.
Author Disclosures
- Amandine Mathias, PhD,
- Guillaume Perriard, PhD,
- Mathieu Canales,
- Fanny Vuilleumier, BS,
- Gaetano Perrotta, MD,
- Myriam Schluep, MD and
- Renaud Du Pasquier, MD
- Amandine Mathias, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Guillaume Perriard, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mathieu Canales,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Fanny Vuilleumier, BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gaetano Perrotta, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Myriam Schluep, MD and
Participation to scientific advisory boards from Biogen, Genzyme, Merck-Serono, Novartis, and Sanofi-Aventis;compensation was paid to the institution.
NONE
Participation to meetings organized by from Biogen, Genzyme, Merck-Serono, Novartis, and Sanofi-Aventis; compensation was paid to the institution.
NONE
NONE
NONE
NONE
Episodic consultancies for Biogen, Merck Serono,Novartis, Genzyme, Sanofi-Aventis; compensation was paid to the institution.
NONE
NONE
NONE
Unrestricted grants from Merck Serono, Novartis and Biogen.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Renaud Du Pasquier, MD
Biogen, Genzyme
NONE
Sanofi, Genzym
Editorial boards of Journal of Neurovirology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Swiss Society for Multiple Sclerosis, Novartis Investigator-initiated trial
NONE
NONE
NONE
NONE
NONE
NONE
- From the Laboratory of Neuroimmunology, Center of Research in Neurosciences (A.M., G. Perriard, M.C., F.V., R.D.P.), and Service of Neurology (G. Perrotta, M.S., R.D.P.), Department of Clinical Neurosciences, CHUV, Lausanne, Switzerland.
- Correspondence to Dr. Du Pasquier: Renaud.Du-Pasquier{at}chuv.ch
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
T-cell response against varicella-zoster virus in fingolimod-treated MS patientsMeret E. Ricklin, Johannes Lorscheider, Anne Waschbisch et al.Neurology, May 22, 2013 -
Article
Varicella-zoster virus vasculopathyImmune characteristics of virus-infected arteriesMaria A. Nagel, Igor Traktinskiy, Kurt R. Stenmark et al.Neurology, December 12, 2012 -
Clinical and Ethical Challenges
The challenging patient with varicella-zoster virus diseaseMaria A. Nagel, Don Gilden et al.Neurology: Clinical Practice, April 15, 2013 -
Articles
Varicella zoster virus vasculopathyAnalysis of virus-infected arteriesM.A. Nagel, I. Traktinskiy, Y. Azarkh et al.Neurology, July 13, 2011